TNFRSF9 and atherosclerosis: The results showed that knock down of CyPA effectively decreased the anti-CD137-induced CyPA and diminished the proatherogenic effect of anti-CD137, whereas restoration of CyPA rescued the anti-CD137L-decreased CyPA and almost completely attenuated the arrested progression of atherosclerosis by anti-CD137L.